These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 39006699)
1. Efficacy and Safety of Combination Therapy With Vaginal and Urethral Erbium-Doped Yttrium-Aluminum-Garnet (Er:YAG) Laser for Overactive Bladder With Urinary Incontinence. Okui N; Okui MA Cureus; 2024 Jun; 16(6):e62363. PubMed ID: 39006699 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists. Okui N World J Urol; 2019 Nov; 37(11):2459-2466. PubMed ID: 30687908 [TBL] [Abstract][Full Text] [Related]
3. Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis. Okui N; Miyazaki H; Takahashi W; Miyauchi T; Ito C; Okui M; Shigemori K; Miyazaki Y; Vizintin Z; Lukac M Lasers Med Sci; 2022 Feb; 37(1):655-663. PubMed ID: 33886071 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause. Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382 [TBL] [Abstract][Full Text] [Related]
6. Discrete Mathematics in Dynamic Network Analysis: Long-Term Efficacy Evaluation of Fotona Laser Therapy for Overactive Bladder Syndrome Using Clustering-Based Patient Subgroup Identification. Okui N; Okui M Cureus; 2024 Sep; 16(9):e68671. PubMed ID: 39371818 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Erbium YAG laser treatment in overactive bladder syndrome: a randomized controlled trial. Chiengthong K; Bunyavejchevin S Menopause; 2023 Apr; 30(4):414-420. PubMed ID: 36854167 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Erbium: Yttrium-Aluminum-Garnet Laser Treatment in Chinese Women with Mild-to-Moderate Stress Urinary Incontinence. Tan Y; Zhang Y; An J; Xu X; Deng J; Chen B; Pan W J Womens Health (Larchmt); 2024 May; 33(5):685-691. PubMed ID: 38563974 [No Abstract] [Full Text] [Related]
9. Laser Treatment for Patients With Vulvodynia and Interstitial Cystitis/Bladder Pain Syndrome: A Case Series (The UNICORN-3 Study). Okui N; Okui MA; Kouno Y; Nakano K Cureus; 2023 Jul; 15(7):e41786. PubMed ID: 37449291 [TBL] [Abstract][Full Text] [Related]
10. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. Okui N World J Urol; 2019 May; 37(5):885-889. PubMed ID: 30116962 [TBL] [Abstract][Full Text] [Related]
11. Mesh Extraction Surgery and Laser Treatment for Pain After Mid-Urethral Sling Surgery: A Case Series. Okui N; Okui MA Cureus; 2024 Jan; 16(1):e51431. PubMed ID: 38169735 [TBL] [Abstract][Full Text] [Related]
12. Effect of Er:YAG Laser for Women with Stress Urinary Incontinence. Lin KL; Chou SH; Long CY Biomed Res Int; 2019; 2019():7915813. PubMed ID: 30766886 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235 [TBL] [Abstract][Full Text] [Related]
14. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response. Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467 [TBL] [Abstract][Full Text] [Related]
15. Impact of combined usage of questionnaire forms with bladder diary for overactive bladder syndrome. Sonbahar AE; Durmaz K; Culha MG Urologia; 2022 Nov; 89(4):517-520. PubMed ID: 35471101 [TBL] [Abstract][Full Text] [Related]
16. The Treatment Selection for a 36-Year-Old Woman With Stress Urinary Incontinence Using a Discrete Mathematical Approach: A Case Report. Okui N Cureus; 2024 May; 16(5):e61314. PubMed ID: 38947714 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study). Yamaguchi O; Kakizaki H; Homma Y; Igawa Y; Takeda M; Nishizawa O; Gotoh M; Yoshida M; Yokoyama O; Seki N; Okitsu A; Hamada T; Kobayashi A; Kuroishi K BJU Int; 2015 Oct; 116(4):612-22. PubMed ID: 25639296 [TBL] [Abstract][Full Text] [Related]
18. Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. Gambacciani M; Fidecicchi T Climacteric; 2022 Apr; 25(2):208-211. PubMed ID: 35006008 [TBL] [Abstract][Full Text] [Related]
19. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment. Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757 [TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome. Yüce T; Dökmeci F; Çetinkaya ŞE Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]